Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SCHIZOPHRENIA 1 (Disorder)”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Post-approval studies (Phase 4)Study completedNCT00524043
What this trial is testing

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Not applicableStudy completedNCT02399020
What this trial is testing

Social Cognition and Interaction Training for Adults With Psychotic Disorders: An Open Pilot Study in Finland

Who this might be right for
Psychotic DisorderCognitive Function 1, Social
Helsinki University Central Hospital 33
Early research (Phase 1)Not Yet RecruitingNCT06793995
What this trial is testing

Effect of Food and Age on the Pharmacokinetics of LY03017

Who this might be right for
Alzheimer's Disease PsychosisParkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 26
Not applicableStudy completedNCT02050854
What this trial is testing

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Who this might be right for
Bipolar 1 DisorderSchizophreniaMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 47
Not applicableStudy completedNCT06890208
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 176
Not applicableNot Yet RecruitingNCT07454200
What this trial is testing

Feasibility, Acceptability, and Effectiveness of a Hatha Yoga-in Patients Hospitalized for Schizophrenia

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)Hospitalized Adult Patients
The Hashemite University 36
Large-scale testing (Phase 3)Study completedNCT00297388
What this trial is testing

How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Post-approval studies (Phase 4)Study completedNCT00159120
What this trial is testing

Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia

Who this might be right for
SchizophreniaPsychoses
Heinrich-Heine University, Duesseldorf 71
Not applicableActive Not RecruitingNCT06304233
What this trial is testing

The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

Who this might be right for
Heart DiseasesHeart; Functional DisturbanceSchizophrenia
Norwegian University of Science and Technology 120
Not applicableUnknownNCT01075373
What this trial is testing

A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations

Who this might be right for
Schizophrenia
National Taiwan University Hospital 360
Large-scale testing (Phase 3)Study completedNCT00600756
What this trial is testing

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone

Who this might be right for
Schizophrenic Disorders
AstraZeneca 798
Early research (Phase 1)Study completedNCT00791232
What this trial is testing

Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113
Not applicableStudy completedNCT07051746
What this trial is testing

Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, or Bipolar Disorder Attending a Psychiatric Day Hospital in Taiwan

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Disorder
ZI-YU LIN 18
Not applicableStudy completedNCT00780585
What this trial is testing

A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)

Who this might be right for
Psychosis
Merck Sharp & Dohme LLC 95
Not applicableStudy completedNCT00288340
What this trial is testing

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

Who this might be right for
SchizophreniaSchizoaffective DisorderHallucinations
Vanderbilt University 60
Testing effectiveness (Phase 2)Study completedNCT02722967
What this trial is testing

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 49
Not applicableStudy completedNCT02922400
What this trial is testing

Social Cognition Assessment in Young Adults

Who this might be right for
Cognitive Function 1, Social
The University of Texas at Dallas 153
Not applicableStudy completedNCT04689867
What this trial is testing

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1

Who this might be right for
SuicidePsychosis
University of Michigan 5
Testing effectiveness (Phase 2)Study completedNCT04030143
What this trial is testing

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 266
Not applicableActive Not RecruitingNCT07427485
What this trial is testing

Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study

Who this might be right for
SCHIZOPHRENIA 1 (Disorder)Schizoaffective Disorder
Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco 40
Load More Results